1998
DOI: 10.1097/00000372-199812000-00145
|View full text |Cite
|
Sign up to set email alerts
|

Cytophagic Histiocytic Panniculitis (Chp)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1999
1999
1999
1999

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…These compounds develop their pharmacological action via the specific inhibition of the subunit-A of the bacterial topoisomerase DNA girase, which controls the shape of DNA [2]. Particular attention was devoted to the light induced degradation of FLQs, as proven by several reports dealing with adverse cutaneous reactions and in vitro phototoxicity through photosensitization under UVA irradiation [3][4][5][6][7][8][9][10][11]. In addition, even photocarcinogenic consequences were reported [12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…These compounds develop their pharmacological action via the specific inhibition of the subunit-A of the bacterial topoisomerase DNA girase, which controls the shape of DNA [2]. Particular attention was devoted to the light induced degradation of FLQs, as proven by several reports dealing with adverse cutaneous reactions and in vitro phototoxicity through photosensitization under UVA irradiation [3][4][5][6][7][8][9][10][11]. In addition, even photocarcinogenic consequences were reported [12][13][14].…”
Section: Introductionmentioning
confidence: 99%